|
1
|
Huwiler A, Kolter T, Pfeilschifter J and
Sandhoff K: Physiology and pathophysiology of sphingolipid
metabolism and signaling. Biochim Biophys Acta. 1485:63–99. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toledo MS, Suzuki E, Handa K and Hakomori
S: Cell growth regulation through GM3-enriched microdomain
(glycosynapse) in human lung embryonal fibroblast WI38 and its
oncogenic transformant VA13. J Biol Chem. 279:34655–34664. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hakomori S: Glycosphingolipids in cellular
interaction, differentiation and oncogenesis. Annu Rev Biochem.
50:733–764. 1981. View Article : Google Scholar
|
|
4
|
Regina-Todeschini A and Hakomori SI:
Functional role of glycosphingolipids and gangliosides in control
of cell adhesion, motility, and growth, through glycosynaptic
microdomains. Biochim Biophys Acta. 1780:421–433. 2008. View Article : Google Scholar
|
|
5
|
Hakomori SI: Glycosynaptic microdomains
controlling tumor cell phenotype through alteration of cell growth,
adhesion, and motility. FEBS Lett. 584:1901–1906. 2010. View Article : Google Scholar :
|
|
6
|
Van Echten G and Sandhoff K: Ganglioside
metabolism. Enzymology, topology, and regulation. J Biol Chem.
268:5341–5344. 1993.PubMed/NCBI
|
|
7
|
Iwabuchi K, Yamamura S, Prinetti A, Handa
K and Hakomori S: GM3- enriched microdomain involvedin cell
adhesion and signal transduction through carbohydrate-carbohydrate
interaction in mouse melanoma B16 cells. J Biol Chem.
273:9130–9138. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kojima N and Hakomori S: Cell adhesion,
spreading, and motility of GM3-expressing cells based on
glycolipid-glycolipid interaction. J Biol Chem. 266:17552–17558.
1991.PubMed/NCBI
|
|
9
|
Hakomori S: Tumor malignancy defined by
aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer
Res. 56:5309–5318. 1996.PubMed/NCBI
|
|
10
|
Birklé S, Zeng G, Gao L, Yu RK and Aubry
J: Role of tumor-associated gangliosides in cancer progression.
Biochimie. 85:455–463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fujimoto Y, Izumoto S, Suzuki T, et al:
Ganglioside GM3 inhibits proliferation and invasion of glioma.
Neurooncol. 71:99–106. 2005. View Article : Google Scholar
|
|
12
|
Kawamura S, Ohyama C, Watanabe R, et al:
Glycolipid composition in bladder tumor: a crucial role of GM3
ganglioside in tumor invasion. Int J Cancer. 94:343–347. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang XQ, Sun P and Paller AS: Ganglioside
GM3 blocks the activation of epidermal growth factor receptor
induced by integrin at specific tyrosine sites. J Biol Chem.
278:48770–48778. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XQ, Sun P, Go L, et al: Ganglioside
GM3 promotes carcinoma cell proliferation via urokinase plasminogen
activator-induced extracellular signal-regulated kinase-independent
p70S6 kinase signaling. J Invest Dermatol. 6:2687–2696. 2006.
View Article : Google Scholar
|
|
15
|
Mitsuzuka K, Handa K, Satoh M, Arai Y and
Hakomori S: A specific microdomain (“glycosynapse 3”) controls
phenotypic conversion and reversion of bladder cancer cells through
GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol
Chem. 280:35545–35553. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saha S and Mohanty KC: Enhancement of
metastatic potential of mouse B16-melanoma cells to lung after
treatment with gangliosides of B-16-melanoma cells of higher
metastatic potential to lung. Indian J Exp Biol. 41:1253–1258.
2003.
|
|
17
|
Gu Y, Zhang J, Mi W, et al: Silencing of
GM3 synthase suppresses lung metastasis of murine breast cancer
cells. Breast Cancer Res. 10:1–12. 2008. View Article : Google Scholar
|
|
18
|
Ladisch S and Gillard B: A solvent
partition method for microscale ganglioside purification. Anal
Biochem. 146:220–231. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Biscardi JS, Maa MC, Tice DA, et al:
c-Src-mediated phosphorylation of the epidermal growth factor
receptor on Tyr845 and Tyr1101 is associated with modulation of
receptor function. J Biol Chem. 274:8335–8343. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bremer EG and Hakomori S: GM3 ganglioside
induces hamster fibroblast growth factor inhibition in chemically
defined medium: ganglioside may regulate growth factor receptor
function. Biochem Biophys Res Commun. 106:711–728. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rebbaa A, Hurh J, Yamamoto K, Kersey D and
Bremer EG: Ganglioside GM3 inhibition of EGF receptor mediated
signal transduction. Glycobiology. 6:399–406. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meuillet E, Cremel G, Dreyfus H and Hicks
D: Differential modulation of basic fibroblast and epidermal growth
factor receptor activation by ganglioside GM3 in cultured retinal
Muller glia. Glia. 17:206–216. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yates AJ, Saqr HE and Van Brocklyn J:
Ganglioside modulation of PDGF receptor. A model for ganglioside
functions. J Neurooncology. 24:65–73. 1995. View Article : Google Scholar
|
|
24
|
Mukherjee P, Faber AC, Shelton LM, et al:
Thematic review series: sphingolipids. Ganglioside GM3 suppresses
the proangiogenic effects of vascular endothelial growth factor and
ganglioside GD1a. J Lipid Res. 49:929–938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chung TW, Kim SJ, Choi HJ, et al:
Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct
interaction of GM3 with VEGFR-2. Glycobiology. 19:229–239. 2009.
View Article : Google Scholar
|
|
26
|
Kawakami Y, Kawakami K, Steelant WF, et
al: Tetraspanin CD9 is a “proteolipid,” and its interaction with
alpha 3 integrin in microdomain is promoted by GM3 ganglioside,
leading to inhibition of laminin-5-dependent cell motility. J Biol
Chem. 277:34349–34358. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ono M, Handa K, Sonnino S, et al: GM3
ganglioside inhibits CD9-facilitated haptotactic cell motility:
coexpression of GM3 and CD9 is essential in the downregulation of
tumor cell motility and malignancy. Biochemistry. 40:6414–6421.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Todeschini AR, Dos Santos JN, Handa K and
Hakomori SI: Ganglioside GM2/GM3 complex affixed on silica
nanospheres strongly inhibits cell motility through
CD82/cMet-mediated pathway. Proc Natl Acad Sci USA. 105:1925–1930.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suárez Pestana E, Greiser U, Sánchez B, et
al: Growth inhibition of human lung adenocarcinoma cells by
antibodies against epidermal growth factor receptor and by
ganglioside GM3: involvement of receptor-directed protein tyrosine
phosphatase(s). Br J Cancer. 75:213–220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suárez Pestana E, Tenev T, Gross S, et al:
The transmembrane protein tyrosine phosphatase RPTP sigma modulates
signaling of the epidermal growth factor receptor in A431 cells.
Oncogene. 18:4069–4079. 1999. View Article : Google Scholar
|
|
31
|
Bassi R, Viani P, Giussani P, Riboni L and
Tettamanti G: GM3ganglioside inhibits endothelin-1-mediated signal
transduction in C6 glioma cells. FEBS Lett. 507:101–104. 2001.
View Article : Google Scholar : PubMed/NCBI
|
